As adoption of healthcare technology accelerates, it’s a good time for healthcare companies to consider investing in digital among nine potential “value pools.”
Insights on Pharmaceuticals & Medical Products
Commercial leaders share the new skills brand marketers need in the digital era to move from brand building to revenue acceleration.
Leaders should consider the lessons and achievements of the COVID-19 crisis in forging new innovation aspirations—and the mechanisms needed to execute them.
Brian Bradbury of Amgen’s Center for Observational Research discusses the power of data and analytics to advance the understanding of disease, therapeutic interventions, and clinical outcomes.
“What I love about medical devices is this enormous capability to deliver a better way of healthcare to so many people across the world.”
The coronavirus pandemic has forced many changes in how life sciences work is done. It may be a misconception that this is the next normal.
Two experts discuss how quantum computing can help solve intractable problems in drug discovery and development.